Question · asked by 1 review
Levosimendan vs enoximone: All‐cause long‐term mortality
- Population
- adults with cardiogenic shock
- Intervention
- Levosimendan
- Comparison
- enoximone
- Outcome
- All‐cause long‐term mortality
The review found no eligible studies for this question.
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Levosimendan vs enoximone All‐cause long‐term mortality · adults with cardiogenic shock The review found no eligible studies for this question. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output… (2020) · Cochrane Headline outcomes only | no estimate extracted | Not reported | No studies found |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome 2020 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.